The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Serum levels of brain-derived neurotrophic factor correlate with the number of T2 MRI lesions in multiple

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

Oligoclonal bands in the cerebrospinal luid and increased brain atrophy in early stages of relapsing-remitting

(A) Brain MRI showing brain cysts in the right hemisphere with midline shift, compression of the lateral ventricles, and white matter changes; (B) MRI with two brain cysts in the

This article describes the clinical and radiological evolution of a stable group of patients with relapsing-remitting multiple sclerosis that had their disease-modifying therapy

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Eficacy in

Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod

Para tanto, procurou-se adaptar para o Brasil o teste realizado por Wolfers 2002 baseado no modelo principal-agente: se os eleitores principais são racionais, no sentido de